S1 of additional material), any intervention that dampens the mechanisms that lead to this state will be positive for any of the 3 conditions.5,6 The mechanisms that underlie the bidirectional association between obesity and immune-mediated diseases7 have not been clearly established, although it is accepted that the skin plays a causative role in chronic inflammation and immune disorders (Fig
Mounjaro is the diabetic brand name and Zepbound is the weight loss brand name
A 2024 pharmacovigilance analysis of a global drug safety database found that GLP-1 receptor agonists, including semaglutide, had reporting-odds ratios suggesting associations with depression, anxiety, and, in rare cases, suicidal ideation
According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), rapid weight loss is a recognized risk factor for gallstone formation
FIGURE 8 Next, we used a highly potent NF-B inhibitor, BAY 11-7082, to further verify the role of NF-B pathway in SGNs damage induced by peroxynitrite (Figure 9)